Labshake search
Citations for Tocris :
101 - 150 of 657 citations for Recombinant Human Interleukin 2 Receptor Alpha His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... the selective D3 receptor agonist PD 128907 (PD; Tocris Bioscience, Bristol, UK) and antagonist SB 277011A (SB ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: A CC-chemokine receptor 5 (CCR5) antagonist (maraviroc; Tocris Biosciences, Bristol, UK) was dissolved in dimethyl sulfoxide and diluted with sterile PBS for further use ...
-
bioRxiv - Neuroscience 2021Quote: ... and TCS-OX2-29 (TCS; OX2 receptor antagonist; 10 µM Tocris, Bristol, UK) were stored as 100 × concentrates at –20 ° C ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 μM picrotoxin – GABAA receptor channel blocker (all from Tocris Bioscience, UK). This cocktail prevented filed potential mediated component of astrocytic current and largely reduced IK (Shih et al. ...
-
bioRxiv - Neuroscience 2020Quote: ... and 100 μM picrotoxin – GABAA receptor channel blocker (all from Tocris Bioscience, UK). This prevented filed potential mediated component of astrocytic current and largely reduced IK (Shih et al. ...
-
bioRxiv - Neuroscience 2020Quote: ... or the D1 receptor antagonist SCH 23390 hydrochloride (Tocris Bioscience, cat no: 0925) at a dose of 0.01 or 0.2 mg/kg ...
-
bioRxiv - Neuroscience 2019Quote: ... and the D1/D2 receptor co-agonist SKF 83959 (10–50 µM; Tocris). For dopamine receptor antagonists we used the D1-like antagonist SCH-23390 (10 µM ...
-
bioRxiv - Physiology 2020Quote: ... injected with the dopamine receptor D2 (DRD2) agonist cabergoline (0.5 mg/kg, Tocris) or saline at 11:00 am ...
-
bioRxiv - Neuroscience 2021Quote: ... and glutamate receptors (NBQX, 10 μM, Tocris; and DL-AP5, 30 μM, Sigma).
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Cat# 4126, Tocris), 10 μM of Rock Inhibitor (Y-27632 ...
-
bioRxiv - Neuroscience 2023Quote: ... The DREADD receptor was activated by intraperitoneal injection of clozapine (0.005mg/kg; Tocris) 5-10 minutes prior to the start of the experiment47,48 ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-HT7 receptor agonist (10-5M AS-19, Tocris, CAS:1000578-26-6). The stock solutions of these drugs were diluted in extracellular physiological saline which contained ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-HT7 receptor antagonist (10-5M Sb 258719, Tocris, CAS:1217674-10-6), 5-HT7 receptor agonist (10-5M AS-19 ...
-
bioRxiv - Neuroscience 2023Quote: ... NMDA- and GABAA- receptors was carried out by using CNQX (10 μM, Tocris), AP-5 (40 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... the GABAA receptor antagonist gabazine (SR 95531 hydrobromide, Tocris, Wiesbaden-Nordenstadt, Germany, 5 μM) was bath-applied for 60 min after having recorded a minimum of 20 min stable baseline responses ...
-
bioRxiv - Neuroscience 2020Quote: ... the reversal potential and the effect of receptor antagonists [10 μM NBQX (Tocris Bioscience) or 20 μM bicuculline (BIC ...
-
bioRxiv - Neuroscience 2022Quote: ... and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5; 50 μM, Tocris).
-
All-optical interrogation of a direction selective retinal circuit by holographic wave front shapingbioRxiv - Neuroscience 2019Quote: ... and the metabotropic glutamate receptor agonist LAP4 (20 μM, catalog no 0103, Tocris Bioscience). The retina was left to rest in the dark for ~ 30-45 min ...
-
bioRxiv - Neuroscience 2020Quote: ... we also added the glutamate receptor antagonists NBQX and CPP (both 10 µM, Tocris). For current-clamp recordings with putative muscarinic receptor-mediated currents ...
-
bioRxiv - Neuroscience 2023Quote: ... the reversal potential and the effect of receptor antagonists [10 μM NBQX (Tocris Bioscience) or 20 μM bicuculline (BIC ...
-
bioRxiv - Neuroscience 2024Quote: ... while block of GABAB receptors was performed by application of 25μM CGP 46381 (Tocris). The locations of each patched cell were logged and displayed in the Figures.
-
bioRxiv - Microbiology 2019Quote: ... and incubated with recombinant protein (GenScript, Sigma, Tocris) of each analyte for 4 h at room temperature ...
-
bioRxiv - Genomics 2019Quote: ... 20ng/ml human LIF (all from WT-MRC Cambridge Stem Cell Institute) and 2 μM Gö6983 (PKCi; Tocris) on Matrigel–coated plates (Corning) ...
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247 ...
-
bioRxiv - Neuroscience 2022Quote: ... We bath-applied the following drugs: picrotoxin (PTX) (GABAA receptor antagonist, 10µM, Tocris Bioscience, #1128) and strychnine hydrochloride (Strych ...
-
bioRxiv - Neuroscience 2019Quote: ... For dopamine receptor antagonists we used the D1-like antagonist SCH-23390 (10 µM; Tocris); the D2-like antagonists sulpiride (20 µM ...
-
bioRxiv - Neuroscience 2020Quote: Designer receptor-ligand clozapine-N-oxide (CNO, Tocris Bioscience; 4936, CAS No: 34233-69-7) was dissolved in 0.9 % saline solution at a concentration of 0.1 mg/ml and administered i.p ...
-
bioRxiv - Neuroscience 2022Quote: ... mEPSCs were recorded in the presence of 3 μM AMPA receptor antagonist NBQX (Tocris Bioscience) in standard external solution.
-
bioRxiv - Cell Biology 2023Quote: ... or 10 μM TGFB receptor inhibitors including SB525334 (Selleckchem S1476) and A83-01 (Tocris 2939) were prepared according to the supplier’s instructions ...
-
bioRxiv - Neuroscience 2023Quote: ... GABAA and glycinergic receptor-mediated synaptic transmission was blocked using 50 μM picrotoxin (Tocris Bioscience), which was prepared from a 100 mM stock solution containing DMSO (final DMSO concentration ...
-
bioRxiv - Neuroscience 2020Quote: ... Substance P was manipulated by injecting the agonist of the NK-1 receptor Substance P (Tocris) to an estimated final concentration of 200 nM ...
-
bioRxiv - Neuroscience 2022Quote: ... to block ionotropic gamma-amino-butyric acid receptors (GABAARs) and 10 μM NBQX (1044, Tocris Biosciences) to inhibit α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) ...
-
bioRxiv - Neuroscience 2021Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2023Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2023Quote: ... were dissolved in HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2023Quote: ... neural medium was additionally supplemented with retinoid X receptor agonist SR 11237 (100 nM; Tocris, 3411). From day 22 ...
-
bioRxiv - Animal Behavior and Cognition 2023Quote: ... As a positive control we used potent agonist of CB1 and CB2 receptors CP55,940 (Tocris, UK). All doses were selected based on our previously published experiments46,50 ...
-
bioRxiv - Bioengineering 2019Quote: ... at 2μM and at 4μM and by blocking the RyR receptors using Ryanodine (Tocris, cat no. 1329). at 10μM ...
-
bioRxiv - Neuroscience 2020Quote: ... EPSCs were induced in the presence of the competitive AMPA receptor antagonist NBQX (3 μM, Tocris Bioscience). Paired-Pulse stimulation for excitatory autapses was assessed by the induction of 2 action potentials with an interstimulus interval of 25 ms ...
-
bioRxiv - Neuroscience 2022Quote: ... To monitor acute changes in [Cl-]i we bath applied GABAA receptor agonist muscimol (Tocris, 10 μM) and imaged at lower resolution (every 2 minutes at a resolution of 4.1 pixels/μm (512×512 pixels ...
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Neuroscience 2024Quote: ... EPSCs were induced in the presence of the competitive AMPA receptor antagonist NBQX (3 µM, Tocris Bioscience). Paired-Pulse stimulation for excitatory autapses was assessed by the induction of 2 action potentials with an interstimulus interval of 20 ms ...
-
bioRxiv - Neuroscience 2021Quote: ... were dissolved in magnesium-free HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2021Quote: ... along with blockers of ionotropic glutamate receptor blockers (DNQX 10 μM and MK801 1 μM, Tocris, Bristol, UK). Wide-field fluorescence imaging of SBFI-AM-stained slices was performed using a digital live acquisition imaging system (Andor Solis version 4.30.30034.0 ...
-
bioRxiv - Neuroscience 2023Quote: ... Then a single bolus of the dopamine D2 receptor agonist sumanirole (30 μM, Tocris No.2773 Abingdon, UK) (52 ...
-
bioRxiv - Neuroscience 2024Quote: ... Mice subsequently received an intraperitoneal injection of 1 mg/kg of the D1 receptor antagonist SCH 23390 (Tocris) and were left undisturbed for 30 minutes at which time the tail-pinch procedure was repeated ...
-
bioRxiv - Biochemistry 2020Quote: ... human BDNF (2837, Tocris), PACAP-38 (4031157 ...
-
bioRxiv - Neuroscience 2022Quote: ... human ghrelin (Tocris, 1463), recombinant mouse leptin (Cedarlane Laboratories Ltd ...
-
bioRxiv - Molecular Biology 2022Quote: ... and for degradation of tagged protein on treatment with dTAGV-1 (Tocris, #6914, reconstituted in DMSO). For all experiments involving dTAGV-1 treatment ...
-
bioRxiv - Neuroscience 2022Quote: ... were recorded during the application of the competitive AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 μM, Tocris) and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5 ...